|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1985-6-25
|
|
pubmed:abstractText |
Friend murine leukemia virus (Fr-MuLV) is a replication-competent murine retrovirus that induces acute nonlymphocytic leukemias in NFS/n mice. Fr-MuLV disease is divided into two stages based on the ability of the leukemia cells to grow in culture and transplant into syngeneic mice. Hematopoietic cells taken from the early stage of disease after Fr-MuLV infection grow as immortal myeloid cell lines in the presence of WEHI-3 cell-conditioned medium (CM) or interleukin 3. These growth factor-dependent cell lines do not grow in culture in the absence of CM and do not form tumors in syngeneic animals. If these Fr-MuLV-infected cells are superinfected with Abelson murine leukemia virus (Ab-MuLV), they lose their dependence on WEHI-3 CM and proliferate in culture in the absence of exogenous growth factors. Concomitant with the loss of growth factor dependence in culture, the Ab-MuLV-infected cell lines become tumorigenic in syngeneic mice. This secondary level of transformation is Ab-MuLV specific. Fr-MuLV-immortalized myeloid cell lines superinfected with Harvey murine sarcoma virus (Ha-MuSV) or amphotropic virus remain dependent on WEHI-3 CM for growth in vitro and are not tumorigenic in vivo. Neither Ab-MuLV- nor Ha-MuSV-infected normal mouse myeloid cell cultures produce growth factor-independent or tumorigenic cell lines. We conclude that at least two genetic events are needed to convert a murine myeloid precursor into a tumorigenic cell line. The first event occurs in Fr-MuLV-infected mice, generating cells that are growth factor dependent but immortal in vitro. The second event, which can be accomplished by Ab-MuLV infection, converts these immortal myeloid precursors into growth factor-independent and tumorigenic cells.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-13702060,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-163444,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-168500,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-168584,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-181592,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-206001,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-219924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-232471,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-311896,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-381791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-4318922,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6095116,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6173755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6245244,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6247414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6258797,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6258798,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6270351,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6275106,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6276011,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6283530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6285602,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6308472,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6308473,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6312107,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6538699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6591200,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-6968334,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-7018622,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2987918-7412807
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3306-10
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2987918-Abelson murine leukemia virus,
pubmed-meshheading:2987918-Animals,
pubmed-meshheading:2987918-Cell Division,
pubmed-meshheading:2987918-Cell Transformation, Viral,
pubmed-meshheading:2987918-Cells, Cultured,
pubmed-meshheading:2987918-Friend murine leukemia virus,
pubmed-meshheading:2987918-Growth Substances,
pubmed-meshheading:2987918-Harvey murine sarcoma virus,
pubmed-meshheading:2987918-Interleukin-3,
pubmed-meshheading:2987918-Leukemia, Experimental,
pubmed-meshheading:2987918-Leukemia Virus, Murine,
pubmed-meshheading:2987918-Lymphokines,
pubmed-meshheading:2987918-Mice,
pubmed-meshheading:2987918-Mice, Inbred Strains,
pubmed-meshheading:2987918-Oncogenes
|
|
pubmed:year |
1985
|
|
pubmed:articleTitle |
Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
